ArticleMolecular therapy. Methods & clinical development2019

GluA4-Targeted AAV Vectors Deliver Genes Selectively to Interneurons while Relying on the AAV Receptor for Entry.

Jessica Hartmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.